ICICI Securities Limited
Archean Chemical’s (ACI) Q2FY24 EBITDA dipped 19.5% YoY to INR 955mn due to lower revenue in bromine business, while industrial salt revenue grew 57.1% YoY. EBITDA margin has been severely impacted by lower bromine revenue mix which has much higher margins.
Deven Choksey released a Accumulate report for Archean Chemical Industries Ltd. with a price target of 704.0 on 13 Aug, 2025.
More from Archean Chemical Industries Ltd.
Recommended